Table 1.
Pharmacokinetic parameters of different doses of AHT-102 after a single intravenous injection in hCD3EDG mice
| Parameters | Unit | AHT-102 (0.1 mg/kg) | AHT-102 (0.5 mg/kg) | AHT-102 (2.5 mg/kg) |
|---|---|---|---|---|
| Kel | 1/h | 0.910 | 0.228 | 0.111 |
| t½ | h | 0.762 | 3.05 | 4.25 |
| Tmax | h | 0.0333 | 0.0333 | 0.0333 |
| Cmax | ng/mL | 2330 | 11,100 | 58,400 |
| AUC(0–t) | h*ng/mL | 1210 | 6270 | 31,900 |
| AUCinf | h*ng/mL | 1220 | 6330 | 32,000 |
| AUCextr | % | 1.45 | 0.958 | 0.391 |
| Vd | mL/kg | 89.9 | 347 | 705 |
| CL | mL/h/kg | 81.8 | 79.0 | 78.2 |
| MRTinf | h | 0.676 | 1.01 | 1.04 |
AUC(0–t) area under the plasma concentration–time curve from zero to the time of the last quantifiable concentration, AUCextr percentage of AUC extrapolated from the last measurable concentration to infinity, AUCinf AUC from time zero to infinity, CL total body clearance, Cmax maximum plasma concentration, Kel terminal elimination rate constant, MRTinf mean residence time from time zero to infinity, t½ terminal half-life, Tmax time to Cmax, Vd volume of distribution.